Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47
Zhengfang Liu1,2,3, Xiumei Zhao4, Maolin Zang2
1Thoracic Surgery Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, 250117, China.
Abstract:
Cancer cell-intrinsic features (e.g., genetic aberrations and dysregulation of signaling pathways) play pivotal roles in orchestrating the composition and functional state of the immune landscape, which in turn impact tumor progression and response to immunotherapy. Here, it is discovered that dysregulation of cancer cell-intrinsic SET and MYND domain-containing protein 3 (SMYD3) leads to the orchestration of an immunosuppressive microenvironment and the impairment of responses to PD-1 blockade by reprogramming the infiltration of immune cells in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). SMYD3 cooperates with Sp1 to transcriptionally promote sterol regulatory element-binding protein 1 (SREBP1) expression by modifying H3-K4 di-/trimethylation and consequently activating the transcription of CD47. CD47, a bridge between innate and adaptive immunity, acts as the downstream effector molecule of the SMYD3 signal to promote the infiltration of T helper 2 (Th2) cells, protecting renal cancer cells from immune attack. In summary, the critical role of the cancer cell-intrinsic SMYD3-SREBP1-CD47 axis is elucidated in regulating the immune microenvironment in ccRCC and provides a potential therapeutic strategy to manipulate the tumor immune milieu in favor of antitumor immunity.
Insights
Dysregulation of SMYD3 in clear cell renal cell carcinoma (ccRCC) creates an immunosuppressive tumor microenvironment. This impairs PD-1 blockade response by promoting T helper 2 cell infiltration via the SMYD3-SREBP1-CD47 axis.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Cancer cell-intrinsic features significantly influence the tumor immune microenvironment and immunotherapy response.
- Clear cell renal cell carcinoma (ccRCC) exhibits complex interactions between tumor cells and immune cells.
- Understanding these interactions is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the role of SET and MYND domain-containing protein 3 (SMYD3) in ccRCC immunity.
- To elucidate the molecular mechanisms by which SMYD3 regulates the tumor immune microenvironment.
- To identify potential therapeutic targets for enhancing immunotherapy in ccRCC.
Main Methods:
- Analysis of cancer cell-intrinsic features and immune cell infiltration in ccRCC.
- Investigating the interaction between SMYD3, Sp1, sterol regulatory element-binding protein 1 (SREBP1), and CD47.
- Assessing the impact of the SMYD3-SREBP1-CD47 axis on T helper 2 cell infiltration and PD-1 blockade response.
Main Results:
- Dysregulated SMYD3 orchestrates an immunosuppressive microenvironment in ccRCC.
- SMYD3 cooperates with Sp1 to upregulate SREBP1 and subsequently CD47 expression.
- The SMYD3-SREBP1-CD47 axis promotes T helper 2 cell infiltration, hindering anti-tumor immunity and PD-1 blockade efficacy.
Conclusions:
- The SMYD3-SREBP1-CD47 axis is a critical regulator of the immune microenvironment in ccRCC.
- Targeting this axis offers a potential strategy to enhance anti-tumor immunity and improve immunotherapy outcomes in ccRCC.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

